About Us
Anthology Fund
Anthology Fund
Anthology Fund Application
Focus Areas
AI
Bio + Healthcare
Consumer
Cloud Infrastructure
Cybersecurity
Fintech
SaaS
Supply Chain + Automation
Team
Portfolio
Perspective
Menlo Fellows
Search for:
Greg yap
Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines
→
Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference
→
Our Investment in Cartwheel: Improving Youth Mental Health
→
Video: Building Riva With Menlo Labs
→
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
→
Video: Early Cancer Detection With Delfi
→
Video: Reengineering Drug Discovery With Recursion
→
Video: Fighting the Opioid Epidemic With Ophelia
→
Carefully Crafted Digital Approaches Can Improve Youths’ Mental Health Care
→
Announcing the Digital Health Founder’s Fellowship
→
Video: Improving Heart Health With Riva
→
Ophelia Health: Fighting the Opioid Epidemic by Making the Best Care Accessible
→
Life Science Is Being Transformed by Vertical SaaS
→
The 5 Ps of Therapeutics Investing at Menlo
→
We Are Hiring a Principal with Therapeutics Expertise: Building a Biotech Franchise at Menlo
→
Our Investment in Riva Health: Building the Future of Cardiovascular Healthcare
→
Doubling Down on H1: Menlo Co-Leads Series B, Eight Months After Leading Series A
→
Four Big Trends in Digital Health
→
Pliant and the 5 Ps of Therapeutics Investing at Menlo
→
Particle: Data Interoperability Powering the Future of Digital Healthcare
→
Investing in H1: SaaS Healthcare Analytics
→
Investing in Benchling: Software Accelerating Life Science Innovation
→
Menlo Ventures’ Greg Yap Selected for Aspen Institute’s Health Innovators Fellowship
→
Menlo Welcomes Greg Yap to Focus on Life Sciences Technology
→
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.
Accept
Decline